NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2023 Earnings Call Transcript August 14, 2023
NRx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $0.14.
Operator: Good day and welcome to the NRX Pharmaceuticals Incorporated Second Quarter 2023 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Mr. Matthew Duffy, the company’s Chief Business Officer. Please go ahead, sir.
Matthew Duffy: Thank you,...
